HELP · NASDAQ · Medical - Pharmaceuticals

Helus Pharma (HELP)

Develops investigational serotonergic therapies for depression and generalized anxiety disorder.

$12.87
vs last close−0.84 (−6.13%)

No ownership filings on record for this listing.